Search research articles
Contact Us
Filters
Showing results (121-130 of 222) with videos related to
Page
of 23
Sort By:
BMC Dermatology
|
October 8, 2016
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial
Kim A Papp, Robert Bissonnette, Melinda Gooderham, et al.
The Journal of Investigative Dermatology
|
June 28, 2017
Response to Hjuler et al
Robert Bissonnette, François Harel, James G Krueger, et al.
The Journal of Investigative Dermatology
|
March 14, 2017
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study
Robert Bissonnette, François Harel, James G Krueger, et al.
Journal of Drugs in Dermatology : JDD
|
October 17, 2017
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis
Robert Bissonnette, Francisco Kerdel, Luigi Naldi, et al.
Eclinicalmedicine
|
February 23, 2023
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
Howard Sofen, Robert Bissonnette, Gil Yosipovitch, et al.
The New England Journal of Medicine
|
February 7, 2024
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis
Robert Bissonnette, Andreas Pinter, Laura K Ferris, et al.
The Journal of Investigative Dermatology
|
February 1, 2021
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
Heena Mehta, Shunya Mashiko, Julianty Angsana, et al.
Journal of Cutaneous Medicine and Surgery
|
November 19, 2010
Canadian hand dermatitis management guidelines
Charles Lynde, Lyn Guenther, Thomas L Diepgen, et al.
The Journal of Allergy and Clinical Immunology
|
March 18, 2020
ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation
Juan Manuel Leyva-Castillo, Claire Galand, Shunya Mashiko, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2017
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis
Joseph F Merola, Alison Potts Bleakman, Alice B Gottlieb, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 222) with videos related to
Sort By:
Page
of 23
BMC Dermatology
|
October 8, 2016
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial
Kim A Papp, Robert Bissonnette, Melinda Gooderham, et al.
The Journal of Investigative Dermatology
|
June 28, 2017
Response to Hjuler et al
Robert Bissonnette, François Harel, James G Krueger, et al.
The Journal of Investigative Dermatology
|
March 14, 2017
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study
Robert Bissonnette, François Harel, James G Krueger, et al.
Journal of Drugs in Dermatology : JDD
|
October 17, 2017
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis
Robert Bissonnette, Francisco Kerdel, Luigi Naldi, et al.
Eclinicalmedicine
|
February 23, 2023
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
Howard Sofen, Robert Bissonnette, Gil Yosipovitch, et al.
The New England Journal of Medicine
|
February 7, 2024
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis
Robert Bissonnette, Andreas Pinter, Laura K Ferris, et al.
The Journal of Investigative Dermatology
|
February 1, 2021
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
Heena Mehta, Shunya Mashiko, Julianty Angsana, et al.
Journal of Cutaneous Medicine and Surgery
|
November 19, 2010
Canadian hand dermatitis management guidelines
Charles Lynde, Lyn Guenther, Thomas L Diepgen, et al.
The Journal of Allergy and Clinical Immunology
|
March 18, 2020
ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation
Juan Manuel Leyva-Castillo, Claire Galand, Shunya Mashiko, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2017
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis
Joseph F Merola, Alison Potts Bleakman, Alice B Gottlieb, et al.
Page
of 23